References
- Fries BC , CoxGM. Cryptococcosis in AIDS. In: Cryptococcus: From Human Pathogen to Model Yeast. Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A (Eds). American Society for Microbiology, Washington, DC, USA, 515–526 (2011).
- Park BJ , WannemuehlerKA, MarstonBJ, GovenderN, PappasPG, ChillerTM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS23(4) , 525–530 (2009).
- Lin X . Cryptococcus neoformans: morphogenesis, infection, and evolution. Infect. Genet. Evol.9(4) , 401–416 (2009).
- Ellis DH , PfeifferTJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet336(8720) , 923–925 (1990).
- Byrnes EJ 3rd, Bartlett KH, Perfect JR, Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect.13(11) , 895–907 (2011).
- Chaturvedi V , ChaturvediS. Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol.19(11) , 564–571 (2011).
- Chaturvedi S , DyavaiahM, LarsenRA, ChaturvediV. Cryptococcus gattii in AIDS patients, southern California. Emerg. Infect. Dis.11(11) , 1686–1692 (2005).
- Prado M , SilvaMB, LaurentiR, TravassosLR, TabordaCP. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem. Inst. Oswaldo Cruz104(3) , 513–521 (2009).
- Kwon-Chung KJ , PerfectJR, LevitzSM. A chronological history of the international conference on Cryptococcus and cryptococcosis (ICCC), an invaluable forum for growth of the cryptococcal research field and clinical practice. Mycopathologia doi:10.1007/s11046-011-9481-z (2011) (Epub ahead of print).
- Wang X , LiW, SunS et al. Know your enemy: how to build and vanquish a global fungal scourge. Mycopathologia doi:10.1007/s11046-011-9484-9 (2011) (Epub ahead of print).
- Pacheco Santos LM , MouraEC, Barradas Barata RDE C et al. Fulfillment of the Brazilian agenda of priorities in health research. Health Res. Policy Syst.9 , 35 (2011).
- Esteves B . Hopes build that new infrastructure can aid drug discovery. Nat. Med.17(10) , 1174–1175 (2011).
- Petherick A . Brazilians lured back home with research funding and stability. Nat. Med.17(10) , 1173–1173 (2011).
- Biomedicine in Brazil. Nat. Med.17(10) , 1169–1169 (2011).
- Kwon-Chung KJ , BoekhoutT, FellJW, DiazM. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon51(4) , 804–806 (2002).
- Mitchell TG , PerfectJR. Cryptococcosis in the era of AIDS – 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev.8(4) , 515–548 (1995).
- Loftus BJ , FungE, RoncagliaP et al. The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Science 307(5713) , 1321–1324 (2005).
- Kidd SE , HagenF, Tscharke Rl et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl Acad. Sci. USA101(49) , 17258–17263 (2004).
- Dixit A , CarrollSF, QureshiST. Cryptococcus gattii: an emerging cause of fungal disease in North America. Interdiscip. Perspect. Infect. Dis.2009 , 840452 (2009).
- Datta K , BartlettKH, BaerR et al. Spread of Cryptococcus gattii into Pacific northwest region of the United States. Emerg. Infect. Dis. 15(8) , 1185–1191 (2009).
- Byrnes EJ , HeitmanJ. Cryptococcus gattii outbreak expands into the Northwestern United States with fatal consequences. F1000 Biol. Rep.1 , 62 (2009).
- Kovacs JA , KovacsAA, PolisM et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103(4) , 533–538 (1985).
- Mukherjee J , ScharffMD, CasadevallA. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun.60(11) , 4534–4541 (1992).
- Roseff SA , LevitzSM. Effect of endothelial cells on phagocyte-mediated anticryptococcal activity. Infect. Immun.61(9) , 3818–3824 (1993).
- Odom A , Del Poeta M, Perfect J, Heitman J. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob. Agents Chemother.41(1) , 156–161 (1997).
- Kwon-Chung KJ . A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia67(6) , 1197–1200 (1975).
- Cherniak R , ReissE, SlodkiME, PlattnerRD, BlumerSO. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A. Mol. Immunol.17(8) , 1025–1032 (1980).
- Bennett JE . Susceptibility of Cryptococcus neoformans to amphotericin B. Antimicrob. Agents Chemother.6 , 405–410 (1966).
- Perfect JR , LangSD, DurackDT. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am. J. Pathol.101(1) , 177–194 (1980).
- Rodrigues ML , CasadevallA. ASM International Fellowship Program catalyzes discovery and collaboration. Microbe4(10) , 467–468 (2009).
- Zaragoza O . Recuerdos de mi experiencia postdoctoral. Actualidad SEM – Sociedad Española de Microbiología49 , 30–32 (2010).
- Silva FD , RossiDCP, MartinezLR et al. Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans. FEMS Microbiol. Lett. 324(1) , 64–72 (2011).
- Meneghini R , PackerAL, Nassi-CaloL. Articles by Latin American authors in prestigious journals have fewer citations. PLoS One3(11) , e3804 (2008).
- Velagapudi R , HsuehYP, Geunes-BoyerS, WrightJR, HeitmanJ. Spores as infectious propagules of Cryptococcus neoformans. Infect. Immun.77(10) , 4345–4355 (2009).
- Barbosa FM , FonsecaFL, HolandinoC, AlvianoCS, NimrichterL, RodriguesML. Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage. Microbes Infect.8(2) , 493–502 (2006).
- Rivera J , FeldmesserM, CammerM, CasadevallA. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect. Immun.66(10) , 5027–5030 (1998).
- Perfect JR . Cryptococcosis. Infect. Dis. Clin. North Am.3(1) , 77–102 (1989).
- Chayakulkeeree M , PerfectJR. Cryptococcosis. Infect. Dis. Clin. North Am.20(3) , 507–544, V–VI (2006).
- Zaragoza O , RodriguesML, De Jesus M, Frases S, Dadachova E, Casadevall A. The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol.68 , 133–216 (2009).
- Casadevall A , NosanchukJD, WilliamsonP, RodriguesML. Vesicular transport across the fungal cell wall. Trends Microbiol.17(4) , 158–162 (2009).
- Rodrigues M l, Djordjevic JT. Unravelling secretion in Cryptococcus neoformans: more than one way to skin a cat. Mycopathologia doi:10.1007/s11046-011-9468-9 (2011) (Epub ahead of print).
- Zaragoza O . Multiple disguises for the same party: the concepts of morphogenesis and phenotypic variations in Cryptococcus neoformans. Front. Microbiol.2 , 181 (2011).
- Garcia-Rodas R , ZaragozaO. Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. doi:10.1111/j.1574- 695X.2011.00871.x (2011) (Epub ahead of print).
- Kozubowski L , LeeSC, HeitmanJ. Signalling pathways in the pathogenesis of Cryptococcus. Cell. Microbiol.11(3) , 370–380 (2009).
- Doering TL . How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans. Annu. Rev. Microbiol.63 , 223–247 (2009).
- Jung WH , KronstadJW. Iron and fungal pathogenesis: a case study with Cryptococcus neoformans. Cell. Microbiol.10(2) , 277–284 (2008).
Websites
- World Factbook 2009. www.cia.gov/library/publications/the-world-factbook/index.html
- Web of Knowledge. www.isiknowledge.com
- SCImago Journal & Country Rank. www.scimagojr.com